Role of celecoxib in reducing cognitive impairment in patients receiving definitive chemoradiation for head and neck carcinoma: A phase II randomized placebo controlled trial (CELCI-HN study)

被引：0
|
作者：
Sharma, Aparna
Sharma, Atul
Thakar, Alok
Bhasker, Suman
Sikka, Kapil
Singh, Amit Chirom
Kumar, Rajeev
Pramanik, Raja
Patil, Vaibhav
Kumar, Akash
Kataria, Babita
Singhal, Abhinav
Panda, Smriti
Sharma, Aman
Izzuddeen, Yousra
Chethan, R.
机构：
[1] All India Inst Med Sci AIIMS, Delhi, India
[2] All India Inst Med Sci AIIMS New Delhi, IRCH, New Delhi, India
[3] All India Inst Med Sci, New Delhi, India
[4] All India Inst Med Sci AIIMS, New Delhi, India
[5] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol & Head & Neck Surg, New Delhi, India
[6] All India Inst Med Sci AIIMS, Dept Otolaryngol & Head & Neck Surg, New Delhi, India
[7] Natl Canc Inst All India Inst Med Sci AIIMS, Jhajjar, India
[8] NCI AIIMS, Radiat Oncol, New Delhi, India
[9] All India Inst Med Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS12150
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Efficacy of Celecoxib during Chemoradiation in Locally Advanced Head and Neck Carcinoma; A Phase 2 Randomized Placebo Control Clinical Trial
    Aghili, Mahdi
    Ghalehtaki, Reza
    Rayzan, Elham
    Farzin, Mostafa
    Mojahed, Mohammad Mahdi
    Izadi, Shahrzad
    Kazemian, Ali
    [J]. INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2021, 14 (05)
  • [2] Randomized, placebo-controlled trial of atorvastatin to prevent hearing loss in patients with head and neck squamous cell carcinoma receiving cisplatin based chemoradiation (CRT)
    Schmitt, Nicole C.
    Fernandez, Katharine
    Newlands, Shawn
    Allen, Paul
    Kaufman, Adam
    McMillan, Garnett P.
    Switchenko, Jeffrey M.
    Stokes, William A.
    Mehra, Ranee
    Mandawat, Anant
    Shamburek, Robert
    Saba, Nabil F.
    Cunningham, Lisa L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Phase 3 Randomized Trial of Topical Steroid Versus Placebo for Prevention of Radiation Dermatitis in Patients With Head and Neck Cancer Receiving Chemoradiation
    Yokota, Tomoya
    Zenda, Sadamoto
    Ota, Ichiro
    Yamazaki, Tomoko
    Yamaguchi, Takuhiro
    Ogawa, Takenori
    Tachibana, Hiroyuki
    Toshiyasu, Takashi
    Homma, Akihiro
    Miyaji, Tempei
    Mashiko, Tomoe
    Hamauchi, Satoshi
    Tominaga, Kuniko
    Ishii, Shinobu
    Otani, Yui
    Orito, Noriko
    Uchitomi, Yosuke
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : 794 - 803
  • [4] Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer
    Lalla, Rajesh V.
    Choquette, Linda E.
    Curley, Kathleen F.
    Dowsett, Robert J.
    Feinn, Richard S.
    Hegde, Upendra P.
    Pilbeam, Carol C.
    Salner, Andrew L.
    Sonis, Stephen T.
    Peterson, Douglas E.
    [J]. ORAL ONCOLOGY, 2014, 50 (11) : 1098 - 1103
  • [5] Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study
    Dechaphunkul, Tanadech
    Arundon, Tippawan
    Raungkhajon, Ponpis
    Jiratrachu, Rungarun
    Geater, Sarayut Lucien
    Dechaphunkul, Arunee
    [J]. CLINICAL NUTRITION, 2022, 41 (02) : 433 - 440
  • [6] Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma
    Ahn, Dongbin
    Lee, Gil Joon
    Sohn, Jin Ho
    Lee, Jeong Eun
    [J]. CANCER MEDICINE, 2020, 9 (24): : 9256 - 9265
  • [7] Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck
    Mix, Michael
    Singh, Anurag K.
    Tills, Michael
    Dibaj, Shiva
    Groman, Adrienne
    Jaggernauth, Wainwright
    Rustum, Youcef
    Jameson, Michael B.
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (05): : 166 - 173
  • [8] A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer
    Mauro Guglielmo
    Patricia Di Pede
    Salvatore Alfieri
    Cristiana Bergamini
    Francesca Platini
    Carla Ida Ripamonti
    Ester Orlandi
    Nicola Alessandro Iacovelli
    Lisa Licitra
    Marta Maddalo
    Paolo Bossi
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2479 - 2487
  • [9] A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer
    Guglielmo, Mauro
    Di Pede, Patricia
    Alfieri, Salvatore
    Bergamini, Cristiana
    Platini, Francesca
    Ripamonti, Carla Ida
    Orlandi, Ester
    Iacovelli, Nicola Alessandro
    Licitra, Lisa
    Maddalo, Marta
    Bossi, Paolo
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2479 - 2487
  • [10] A Phase III Randomized Clinical Trial Study of Chemoradiation using Lovastatin/Cisplatin in Patients with Head and Neck Squamous Cell Carcinoma
    Razmjoo, Sasan
    Hosseini, Seyed Mohammad
    Shahbazian, Hojatollah
    Arvandi, Shole
    Ghadamgahi, Pari
    [J]. MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (01) : 120 - 127
12345